Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Debt to Equity (2019 - 2025)

OptimizeRx's Debt to Equity history spans 4 years, with the latest figure at $0.23 for Q3 2025.

  • For Q3 2025, Debt to Equity fell 25.42% year-over-year to $0.23; the TTM value through Sep 2025 reached $0.23, down 25.42%, while the annual FY2024 figure was $0.28, 2.03% down from the prior year.
  • Debt to Equity for Q3 2025 was $0.23 at OptimizeRx, down from $0.24 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.31 in Q3 2024 and bottomed at $0.23 in Q3 2025.
  • The 3-year median for Debt to Equity is $0.28 (2023), against an average of $0.28.
  • The largest annual shift saw Debt to Equity fell 2.03% in 2024 before it decreased 25.42% in 2025.
  • A 3-year view of Debt to Equity shows it stood at $0.29 in 2023, then decreased by 2.03% to $0.28 in 2024, then fell by 18.06% to $0.23 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Debt to Equity are $0.23 (Q3 2025), $0.24 (Q2 2025), and $0.28 (Q1 2025).